v3.25.1
Segment Information - Summary of Segment's Financial Information (Details)
 3 Months Ended
Mar. 31, 2025
USD ($)
segment
Mar. 31, 2024
USD ($)
Segment Reporting [Abstract]    
Number of operating segments | segment 1  
Revenue:    
Total revenue $ 25,427 $ 9,302
Indirect costs:    
General and administrative 2,309,164 2,670,581
Total operating expenses 4,606,545 6,031,775
Loss from operations (4,581,118) (6,022,473)
Other income (expense), net 202,811 (732,883)
Net loss (4,378,307) (6,755,356)
Reportable Segment    
Revenue:    
Total revenue 25,427 9,302
Direct program costs:    
Contra-R&D expenses (2,618,373) (2,652,715)
Total research and development direct program costs 1,174,790 2,051,988
Indirect costs:    
Contra R&D expenses (448,392) (259,264)
Total research and development indirect costs 1,122,591 1,301,532
Other operating expenses 0 7,674
Total operating expenses 4,606,545 6,031,775
Loss from operations (4,581,118) (6,022,473)
Interest expense 134,050 209,138
Interest income (156,621) (88,133)
Other income (expense), net 180,240 (611,878)
Net loss (4,378,307) (6,755,356)
Reportable Segment | Royalty revenue    
Revenue:    
Total revenue 25,427 9,302
Reportable Segment | Ovaprene    
Direct program costs:    
Direct program costs: 1,495,727 2,183,873
Reportable Segment | Sildenafil Cream, 3.6%    
Direct program costs:    
Direct program costs: 211,389 460,107
Reportable Segment | Other advanced clinical stage programs    
Direct program costs:    
Direct program costs: 490,562 446,671
Reportable Segment | Phase 1 and Phase 1-ready clinical stage programs    
Direct program costs:    
Direct program costs: 496,747 229,550
Reportable Segment | Preclinical stage programs    
Direct program costs:    
Direct program costs: 1,098,738 1,371,708
Reportable Segment | Other development programs    
Direct program costs:    
Direct program costs: 0 12,794
Reportable Segment | Personnel-related (including stock compensation)    
Indirect costs:    
Indirect costs: 1,492,248 1,482,597
Reportable Segment | Other indirect costs    
Indirect costs:    
Indirect costs: $ 78,735 $ 78,199